Chiedzo Mpofu

1.4k total citations · 1 hit paper
10 papers, 988 citations indexed

About

Chiedzo Mpofu is a scholar working on Rheumatology, Genetics and Genetics. According to data from OpenAlex, Chiedzo Mpofu has authored 10 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 4 papers in Genetics and 3 papers in Genetics. Recurrent topics in Chiedzo Mpofu's work include Rheumatoid Arthritis Research and Therapies (4 papers), Inflammatory Bowel Disease (4 papers) and Microscopic Colitis (2 papers). Chiedzo Mpofu is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Inflammatory Bowel Disease (4 papers) and Microscopic Colitis (2 papers). Chiedzo Mpofu collaborates with scholars based in United Kingdom, Switzerland and Canada. Chiedzo Mpofu's co-authors include Jonathan M. Rhodes, Barry J. Campbell, C. Anthony Hart, Manu Nayar, Ravinder Singh, Helen Martin, Hans Englyst, Paul Collins, Alastair J.M. Watson and JM Rhodes and has published in prestigious journals such as Gastroenterology, Cochrane Database of Systematic Reviews and Annals of the Rheumatic Diseases.

In The Last Decade

Chiedzo Mpofu

9 papers receiving 970 citations

Hit Papers

Enhanced Escherichia coli adherence and invasion in Crohn... 2004 2026 2011 2018 2004 100 200 300 400 500

Peers

Chiedzo Mpofu
Chiedzo Mpofu
Citations per year, relative to Chiedzo Mpofu Chiedzo Mpofu (= 1×) peers K-H MEYER ZUM BÜSCHENFELDE

Countries citing papers authored by Chiedzo Mpofu

Since Specialization
Citations

This map shows the geographic impact of Chiedzo Mpofu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiedzo Mpofu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiedzo Mpofu more than expected).

Fields of papers citing papers by Chiedzo Mpofu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiedzo Mpofu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiedzo Mpofu. The network helps show where Chiedzo Mpofu may publish in the future.

Co-authorship network of co-authors of Chiedzo Mpofu

This figure shows the co-authorship network connecting the top 25 collaborators of Chiedzo Mpofu. A scholar is included among the top collaborators of Chiedzo Mpofu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiedzo Mpofu. Chiedzo Mpofu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Brandes, Alba A., Frank Saran, Alain Carpentier, et al.. (2017). ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA. Neuro-Oncology. 19(suppl_6). vi17–vi18. 1 indexed citations
2.
Emery, Paul, J.E. Gottenberg, Andrea Rubbert‐Roth, et al.. (2014). Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. Annals of the Rheumatic Diseases. 74(6). 979–984. 112 indexed citations
3.
Jones, Graeme, Anthony Sebba, Jenny Devenport, et al.. (2013). FRI0248 Long-term efficacy and safety of tocilizumab (TCZ) monotherapy in patients (PTS) with rheumatoid arthritis (RA) previously methotrexate (MTX) naive or mtx free for 6 months prior to study start. Annals of the Rheumatic Diseases. 72. A457–A458. 2 indexed citations
6.
Mpofu, Chiedzo, Barry J. Campbell, Sreedhar Subramanian, et al.. (2007). Microbial Mannan Inhibits Bacterial Killing by Macrophages: A Possible Pathogenic Mechanism for Crohn’s Disease. Gastroenterology. 133(5). 1487–1498. 52 indexed citations
7.
Collins, Paul, Chiedzo Mpofu, Alastair J.M. Watson, & Jonathan M. Rhodes. (2006). Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database of Systematic Reviews. CD000279–CD000279. 201 indexed citations
8.
Martin, Helen, Barry J. Campbell, C. Anthony Hart, et al.. (2004). Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer 1 1The authors thank Professor T. K. Korhonen (Division of General Microbiology, University of Helsinki, Finland), who kindly donated Escherichia coli IH11165; Professor J.-F. Colombel (Laboratoire de Recherche sur les Maladies Inflammatoire de l’Intestine, Centre Hospitalier Universitaire, Lille, France) and Professor A. Darfeuille-Michaud (Faculte de Pharmacie, Clermont-Ferrand, France), who kindly donated the Crohn’s disease ileal isolates LF10 and LF82; and Dr. Keith Leiper (Gastroenterology Unit, Royal Liverpool & Broadgreen University Hospitals Trust, Liverpool, UK) for his cooperation in obtaining colorectal tissue specimens.As a consequence of the work described herein, a patent application has been filed by the University of Liverpool regarding the use of soluble plantain fiber in Crohn’s disease.. Gastroenterology. 127(1). 80–93. 575 indexed citations breakdown →
9.
Mpofu, Chiedzo, Andrew Watson, & JM Rhodes. (2004). Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database of Systematic Reviews. CD000279–CD000279. 31 indexed citations
10.
Mpofu, Chiedzo, et al.. (1991). No sensory neuropathy during pyridoxine treatment in homocystinuria.. Archives of Disease in Childhood. 66(9). 1081–1082. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026